Clinical trial
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
NCT00324311 · MediWound Ltd, Industry · Completed
Key facts
| NCT number | NCT00324311 |
|---|---|
| Title | Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care |
| Official title | Enzymatic Debridement in Burns Patients (Children & Adults): A Comparison to Standard of Care (Protocol MW 2004-11-02) |
| Lead sponsor | MediWound Ltd, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Burn |
| Intervention type | Drug |
| Interventions | DGD |
| Enrollment | 182 |
| Start date | Dec 1, 2005 |
| Primary completion | Oct 1, 2009 |
| Completion | Feb 1, 2010 |
| First posted | May 11, 2006 |
| Last update posted | May 10, 2011 |
| Countries | Australia, Brazil, France, Germany, Israel, Italy, Poland, Romania, Slovakia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: